108 related articles for article (PubMed ID: 28294390)
1. Combined XIL-6R and urocortin-2 treatment restores MDX diaphragm muscle force.
Manning J; Buckley MM; O'Halloran KD; O'Malley D
Muscle Nerve; 2017 Dec; 56(6):E134-E140. PubMed ID: 28294390
[TBL] [Abstract][Full Text] [Related]
2. Recovery of respiratory function in mdx mice co-treated with neutralizing interleukin-6 receptor antibodies and urocortin-2.
Burns DP; Canavan L; Rowland J; O'Flaherty R; Brannock M; Drummond SE; O'Malley D; Edge D; O'Halloran KD
J Physiol; 2018 Nov; 596(21):5175-5197. PubMed ID: 30160301
[TBL] [Abstract][Full Text] [Related]
3. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
[TBL] [Abstract][Full Text] [Related]
4. In vivo neutralization of IL-6 receptors ameliorates gastrointestinal dysfunction in dystrophin-deficient mdx mice.
Manning J; Buckley MM; O'Halloran KD; O'Malley D
Neurogastroenterol Motil; 2016 Jul; 28(7):1016-26. PubMed ID: 26920808
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse.
Austin L; Bower JJ; Bennett TM; Lynch GS; Kapsa R; White JD; Barnard W; Gregorevic P; Byrne E
Muscle Nerve; 2000 Nov; 23(11):1700-5. PubMed ID: 11054748
[TBL] [Abstract][Full Text] [Related]
7. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.
Gregorevic P; Plant DR; Leeding KS; Bach LA; Lynch GS
Am J Pathol; 2002 Dec; 161(6):2263-72. PubMed ID: 12466140
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
9. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
[TBL] [Abstract][Full Text] [Related]
10. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm.
Pauly M; Daussin F; Burelle Y; Li T; Godin R; Fauconnier J; Koechlin-Ramonatxo C; Hugon G; Lacampagne A; Coisy-Quivy M; Liang F; Hussain S; Matecki S; Petrof BJ
Am J Pathol; 2012 Aug; 181(2):583-92. PubMed ID: 22683340
[TBL] [Abstract][Full Text] [Related]
11. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.
Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD
J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155
[TBL] [Abstract][Full Text] [Related]
12. Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Neuromuscul Disord; 2001 Mar; 11(2):192-6. PubMed ID: 11257477
[TBL] [Abstract][Full Text] [Related]
13. Inotrophic effects of the K(+) channel blocker TEA on dystrophic (mdx and dy/dy) mouse diaphragm.
van Lunteren E; Manubay P
Respir Physiol; 2001 Apr; 125(3):249-54. PubMed ID: 11282391
[TBL] [Abstract][Full Text] [Related]
14. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
[TBL] [Abstract][Full Text] [Related]
15. Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice.
Hinkle RT; Lefever FR; Dolan ET; Reichart DL; Dietrich JA; Gropp KE; Thacker RI; Demuth JP; Stevens PJ; Qu XA; Varbanov AR; Wang F; Isfort RJ
BMC Med; 2007 Jul; 5():18. PubMed ID: 17626629
[TBL] [Abstract][Full Text] [Related]
16. mdx(⁵cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice.
Beastrom N; Lu H; Macke A; Canan BD; Johnson EK; Penton CM; Kaspar BK; Rodino-Klapac LR; Zhou L; Janssen PM; Montanaro F
Am J Pathol; 2011 Nov; 179(5):2464-74. PubMed ID: 21893021
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid therapy does not alter the threshold for contraction-induced injury in dystrophic (mdx) mouse diaphragm.
Yang L; Luo J; Petrof BJ
Muscle Nerve; 1998 Mar; 21(3):394-7. PubMed ID: 9486869
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
Gosselin LE; Williams JE
Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
[TBL] [Abstract][Full Text] [Related]
19. Nutraceutical and pharmaceutical cocktails did not preserve diaphragm muscle function or reduce muscle damage in D2-mdx mice.
Spaulding HR; Quindry T; Quindry JC; Selsby JT
Exp Physiol; 2020 Jun; 105(6):989-999. PubMed ID: 32267561
[TBL] [Abstract][Full Text] [Related]
20. Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice.
Selsby JT; Ballmann CG; Spaulding HR; Ross JW; Quindry JC
J Physiol; 2016 Oct; 594(20):6037-6053. PubMed ID: 27094343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
